EUVIMEDEUVIMED entdecken
Crossref

Comorbidity spectrum in children and youth with epilepsy based on a validated and classified population‐based childhood epilepsy cohort

Kari Modalsli Aaberg iD, Truls Vikin iD, Dag Hofoss iD, Morten I Lossius iD, Ragnhild E Brandlistuen iD, Richard F M Chin iD

Epilepsia · 2026

DOI: 10.1002/epi.70391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Kari Modalsli Aaberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Neuroscience, National Center for Epilepsy, full member of European Reference Network EpiCARE, Oslo University Hospital, Oslo, N…. Hauptthemen laut MEDLINE: Epilepsy, Neurodevelopmental Disorders, Mental Disorders, Nervous System Diseases. Die Arbeit nennt 52 Literaturangaben. Gefördert von: EkstraStiftelsen Helse og Rehabilitering (Stiftelsen Dam), Helse Sør-Øst RHF, Stiftelsen Dam.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to describe the occurrence and distribution of medical, neurological, neurodevelopmental, and psychiatric comorbidities in children and youth with epilepsy (CYE) and risk factors of such conditions.

Methods

The study platform is the Norwegian Pediatric Epilepsy Study (NorPec), a nested case–cohort study within the Norwegian Mother, Father, and Child Cohort Study (MoBa). MoBa includes more than 113 000 children with consent for prospective follow‐up with questionnaires and registry linkages. NorPec consists of all MoBa children with validated epilepsy diagnoses according to contemporary International League Against Epilepsy definitions and classifications. Information on comorbidities and epilepsy characteristics was based on structured medical record reviews. Differences across categorical variables were tested with chi‐squared tests. Risk factors of comorbid categories were assessed using logistic regression models.

Results

Among 1054 CYE, 78% had any comorbid condition. Medical conditions were reported in 62%, neurological conditions in 39%, psychiatric conditions in 32%, and neurodevelopmental impairments in 51%. Most CYE with structural etiologies had medical (78%), neurological (78%), and/or neurodevelopmental (70%) comorbidities. Most CYE with developmental and epileptic encephalopathies (DEEs), genetic etiology, and/or combined epilepsy had not only neurodevelopmental comorbidities (93%–98%) but also neurological (83%–92%) and medical (90%–95%) comorbidities. Neurodevelopmental impairments were still present in self‐limited (25%) and genetic generalized epilepsies (33%) and epilepsies of unknown etiologies (42%). Genetic etiology was associated with increased odds of medical comorbidity, structural etiologies with neurological comorbidity, and DEEs with increased odds of neurodevelopmental and neurological comorbidity but reduced odds of reported psychiatric comorbidity. Neurodevelopmental comorbidity was associated with increased odds of medical, neurological, and psychiatric comorbidities overall, but affective conditions were less frequent in DEEs. Heredity, sex, neonatal events, etiology, syndrome category, and having other comorbidities influenced risk of comorbid categories in CYE. Significance Most CYE have a wide spectrum of medical, neurological, psychiatric, and neurodevelopmental comorbidities. Thus, their evaluation and management need to extend beyond seizures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyNeurodevelopmental DisordersMental DisordersNervous System DiseasesHumansComorbidityFemaleNorwayChildMaleAdolescentRisk FactorsChild, PreschoolCohort StudiesInfantRegistries

Stichwörter der Autor:innen

Norwegian Mother, Father, and Child Cohort Study (MoBa)medical comorbiditiesneurodevelopmental comorbiditiesneurological comorbiditiespsychiatric comorbidities

Autor:innen und Institutionen

  • Division of Clinical Neuroscience, National Center for Epilepsy, full member of European Reference Network EpiCARE, Oslo University Hospital, Oslo, Norway.
  • Department of Rare Diseases, Norwegian Center for Rare Diseases, Oslo University Hospital, Oslo, Norway.
  • Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.
  • Department of Paediatric Neurosciences, Royal Hospital for Children and Young People, Edinburgh, UK.
  • Muir Maxwell Epilepsy Centre, Institute for Neuroscience and Cardiovascular Research, The University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Kari Modalsli Aaberg, Truls Vikin, Dag Hofoss, Morten I Lossius, Ragnhild E Brandlistuen, Richard F M Chin

Förderung

  • EkstraStiftelsen Helse og Rehabilitering (Stiftelsen Dam)
  • Helse Sør-Øst RHF
  • Stiftelsen Dam

Zitieren

APA

Aaberg, K. M., Vikin, T., Hofoss, D., Lossius, M. I., Brandlistuen, R. E., & Chin, R. F. M. (2026). Comorbidity spectrum in children and youth with epilepsy based on a validated and classified population‐based childhood epilepsy cohort. Epilepsia. https://doi.org/10.1002/epi.70391

Vancouver

Aaberg KM, Vikin T, Hofoss D, Lossius MI, Brandlistuen RE, Chin RFM. Comorbidity spectrum in children and youth with epilepsy based on a validated and classified population‐based childhood epilepsy cohort. Epilepsia. 2026. doi:10.1002/epi.70391

BibTeX
@article{Aaberg2026,
  author = {Aaberg, Kari Modalsli and Vikin, Truls and Hofoss, Dag and Lossius, Morten I and Brandlistuen, Ragnhild E and Chin, Richard F M},
  title = {Comorbidity spectrum in children and youth with epilepsy based on a validated and classified population‐based childhood epilepsy cohort},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70391}
}
Kostenlos starten →